Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Testicular rhabdomyosarcoma after chemotherapy for metastatic germ cell tumors.
Nakagawa R, Aoyama S, Urata S, Ofude M, Miyagi T, Nakashima T, Okayama Y, Katayanagi K. Nakagawa R, et al. Among authors: aoyama s. Int Cancer Conf J. 2019 Jun 15;8(4):175-180. doi: 10.1007/s13691-019-00378-2. eCollection 2019 Oct. Int Cancer Conf J. 2019. PMID: 31559118 Free PMC article.
Favorable Response of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma with Only Small Lesions to not be Considered Measurable by RECIST.
Kadono Y, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kamijima T, Seto C, Takano A, Yotsuyanagi S, Nakagawa R, Miyagi T, Aoyama S, Asahi H, Fukuda R, Mizokami A. Kadono Y, et al. Among authors: aoyama s. Urol J. 2021 Dec 20;19(3):202-208. doi: 10.22037/uj.v18i.6652. Urol J. 2021. PMID: 34927229 Free article.
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer.
Iwamoto H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Shimada T, Kano H, Makino T, Naito R, Kadomoto S, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Mizokami A. Iwamoto H, et al. Among authors: aoyama s. Biomedicines. 2022 Sep 22;10(10):2369. doi: 10.3390/biomedicines10102369. Biomedicines. 2022. PMID: 36289628 Free PMC article.
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
Kano H, Izumi K, Hiratsuka K, Toriumi R, Nakagawa R, Aoyama S, Kamijima T, Shimada T, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Saito Y, Nakagawa-Goto K, Yoshioka K, Nakata H, Lin WJ, Mizokami A. Kano H, et al. Among authors: aoyama s. Cancer Sci. 2023 Apr;114(4):1479-1490. doi: 10.1111/cas.15683. Epub 2022 Dec 18. Cancer Sci. 2023. PMID: 36479732 Free PMC article.
Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells.
Shimada T, Naito R, Toriumi R, Nakagawa R, Aoyama S, Kamijima T, Kano H, Kadomoto S, Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Nakata H, Saito Y, Nakagawa-Goto K, Mizokami A. Shimada T, et al. Among authors: aoyama s. Anticancer Res. 2023 Jun;43(6):2433-2444. doi: 10.21873/anticanres.16411. Anticancer Res. 2023. PMID: 37247901
Role of Positive Biopsy Core Ratio in Prostate Cancer Patients.
Kano H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Shimada T, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Mizokami A. Kano H, et al. Among authors: aoyama s. Anticancer Res. 2023 Oct;43(10):4619-4626. doi: 10.21873/anticanres.16656. Anticancer Res. 2023. PMID: 37772589
366 results